Efficacy / Effect
Immunization against infection caused by all known subtypes of Hepatitis B virus
Usage/Dosage
0.5 mL (10 μg HBsAg) is administered to neonates, infants, and children aged up to 15 years and 1.0 mL (20 μg HBsAg) is administered to adults aged from 16 years, by intramuscular injection
* Basic immunization schedule: 0-1-6 months
* Alternate immunization schedule: 0-1-2 months
etc.
Appearance & Packaging Unit
Slightly opaque white suspension for injection
10 μg/0.5 mL 1, 10 vials, 20 vials
20 μg/1.0 mL 1, 10 vials, 20 vials
Active Ingredient and Capacity
Each mL of Euvax B™ Inj. contains, 20 μg of Purified HBsAg (rDNA) as active ingredient and
0.5 mg of Aluminum hydroxide gel (as Al) as adjuvant.
Storage
Store at 2-8°C. Do not freeze.
Advanced Adhesive Products and Their Functions